Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
Müfide OkayYahya BuyukasikHaluk DemİroğluUmit Yavuz MalkanRafiye CiftcilerElifcan AladagSalih Aksuİbrahim Celallettin HaznedaroğluNilgün SayınalpOsman Ilhami ÖzcebeHakan GokerPublished in: Turkish journal of medical sciences (2019)
High-dose chemotherapy followed by ASCT is an effective conditioning regimen in relapsed/refractory
lymphoma patients who are undergoing ASCT.
Keyphrases
- high dose
- stem cell transplantation
- diffuse large b cell lymphoma
- low dose
- acute lymphoblastic leukemia
- end stage renal disease
- acute myeloid leukemia
- multiple myeloma
- hodgkin lymphoma
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- bone marrow
- squamous cell carcinoma
- stem cells
- radiation therapy
- patient reported outcomes